Global Bladder Cancer Treatment Market to Reach US$ 6.7 Billion by 2032, Stimulated by the Increasing Incidences of Bladder Cancer

December 18, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Bladder Cancer Treatment Market Report by Type (Invasive Bladder Cancer, Transitional Bladder Cancer, Superficial Bladder Cancer, Squamous Cell Bladder Cancer, and Others), Diagnosis and Treatment (Diagnosis, Treatment), Treatment Channel (Public, Private), and Region 2024-2032,” the global bladder cancer treatment market size reached US$ 4.4 Billion in 2023. Bladder cancer treatment typically involves a combination of therapies tailored to the stage and grade of the cancer, as well as the overall health of a patient. The primary treatment options for bladder cancer include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy. Surgery is often the initial approach, with procedures like transurethral resection of the bladder tumor (TURBT) used for early-stage cancers confined to the bladder lining. Bladder cancer treatment in some cases requires urinary diversion procedures to manage urine drainage. On the other hand, for more advanced cases of bladder cancer, the entire bladder (cystectomy) is removed.

Global Bladder Cancer Treatment Market Trends:

One of the primary factors driving the market is the rising incidences of bladder cancer worldwide. Factors, such as aging population, tobacco smoking, exposure to industrial chemicals, and changing lifestyles, have contributed to the growing number of bladder cancer cases. Additionally, the emphasis on early detection and screening programs has increased awareness and led to the diagnosis of bladder cancer at earlier stages. This, in turn, has fueled the demand for treatment options, catalyzing the market growth. Other than this, as the global population ages, there is a higher likelihood of bladder cancer cases, which drives the need for effective treatments and therapies. Besides this, the overall increase in healthcare expenditure, particularly in developing regions, allows for greater access to advanced bladder cancer treatments and therapies. In line with this, patients are becoming more informed about bladder cancer and available treatment options through online resources and patient advocacy groups. Informed patients are more likely to seek appropriate treatment, thus contributing to market growth. Furthermore, the expansion of pharmaceutical companies into emerging markets and the development of new drugs are other major growth-inducing factors. In line with this, regulatory agencies, such as the United States Food and Drug Administration (USFDA) and the European Medicines Agency (EMA), play a crucial role in facilitating the approval and commercialization of new bladder cancer treatments. Looking forward, the market value is projected to reach US$ 6.7 Billion by 2032, expanding at a CAGR of 4.8% during 2024-2032.

Market Summary:

  • Based on the type, the market has been segmented into invasive bladder cancer (non-muscle-invasive bladder cancer and muscle-invasive bladder cancer), transitional bladder cancer, superficial bladder cancer, squamous cell bladder cancer, and others. Presently, transitional bladder cancer holds the largest segment.
  • On the basis of the treatment, the market has been divided into diagnosis (cystoscopy, biopsy, urine cytology, and imaging tests) and treatment (surgery, intravesical chemotherapy, systemic chemotherapy, radiation therapy, immunotherapy, and targeted therapy).
  • Based on the treatment channel, the market has been segregated into public and private.
  • Region-wise, the market has been segmented into North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Presently, North America exhibits a clear dominance in the market.
  • The competitive landscape of the market has also been examined, with some of the key players being Bristol-Myers Squibb Co., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., etc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Type
  • Diagnosis and Treatment
  • Treatment Channel
  • Region
Types Covered
  • Invasive Bladder Cancer: Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer
  • Transitional Bladder Cancer
  • Superficial Bladder Cancer
  • Squamous Cell Bladder Cancer
  • Others
Diagnosis and Treatments Covered
  • Diagnosis: Cystoscopy, Biopsy, Urine Cytology, Imaging Tests
  • Treatment: Surgery, Intravesical Chemotherapy, Systemic Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy
Treatment Channels Covered Public, Private
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Bristol-Myers Squibb Co., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Bladder Cancer Treatment Market to Reach US$ 6.7 Billion by 2032, Stimulated by the Increasing Incidences of Bladder Cancer
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More